Genscript Biotech's total assets for Q2 2024 were $3.33B, a decrease of -1.64% from the previous quarter. HK:1548 total liabilities were $1.51B for the fiscal quarter, a 12.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.